 Braxia Scientific Corp CSE:BRAX OTCMKTS:BRAXF FRA:496 is set to start the largest registered trial of ketamine treatment for depression with funding from the Canadian government. The psychedelic medicine company announced it was awarded funding from the Canadian Institute of Health Research CIHR, part of the Government of Canada, to support the clinical trial for bipolar depression. 